Four weeks of 45-minute daily treadmill exercise significantly reversed diabetes-induced hippocampal deterioration in 16-month-old female Wistar rats. Streptozotocin-induced diabetes elevated hippocampal Nogo-A (a neurite outgrowth inhibitor) and MDA (lipid peroxidation marker) while suppressing KLOTHO, NZF-2b, and glutathione (GSH). Chronic moderate exercise restored all five biomarkers toward control levels and improved rotarod motor performance scores, which had fallen lowest in the diabetic-sedentary group (n=10 per group, p<0.05 throughout).
The simultaneous rescue of KLOTHO — an anti-aging hormone increasingly linked to cognitive resilience — alongside NZF-2b transcriptional upregulation is the most compelling mechanistic thread here. KLOTHO deficiency has been independently associated with accelerated brain aging and reduced synaptic plasticity in prior human and rodent work, so its exercise-driven recovery adds a concrete molecular rationale to what epidemiology has long suggested: physically active older adults with diabetes suffer less cognitive decline. The NZF-2b finding is newer and less characterized, hinting that exercise may recruit transcriptional cascades beyond the well-worn BDNF pathway.
Limitations are substantial: 40 rats total, all female, all one species, with streptozotocin as an imperfect Type 1 diabetes model that may not fully represent the Type 2 metabolic environment common in aging humans. Causality within the hippocampus versus systemic glycemic improvement also cannot be disentangled here. Nonetheless, the multi-marker convergence — oxidative, structural, transcriptional, and behavioral — makes this an incrementally important confirmation that moderate aerobic exercise is genuinely neuroprotective, not merely symptom-masking, in the diabetic aging brain.
